retatrutide peptide fda approval for weight loss: Study shows 30% body weight loss Retatrutide Explained: Benefits, Mechanism &

In overweight or obese patients without diabetes mellitus, patients treated with GLP-1 RAs had significantly reduced major adverse cardiovascular events, all-cause death, myocardial infarction, and revascularization when compared with placebo [36] [37] [38]

Not only are there currently millions of people on these compounded drugs, all of whom would have to get new prescriptions to switch over to brand-name ones, but the market is ever-growing as these drugs gain new approved uses, like sleep apnea

Amgen updated data from its Phase I study of the weight loss drug AMG133 at the 2022 American Heart Association Annual Scientific Sessions (AHA)

The meal containing eggs was associated with lower post-meal blood glucose levels, reduced feelings of hunger, and decreased food intake over the next 24 hours